These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31262163)

  • 1. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas.
    Buchynska LG; Brieieva OV; Iurchenko NP
    Exp Oncol; 2019 Jun; 41(2):138-143. PubMed ID: 31262163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
    Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
    Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.
    Noske A; Brandt S; Valtcheva N; Wagner U; Zhong Q; Bellini E; Fink D; Obermann EC; Moch H; Wild PJ
    Oncotarget; 2017 Feb; 8(9):14794-14805. PubMed ID: 27582547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular phenotype of high-grade endometrioid carcinoma of the endometrium.
    Buchynska LG; Glushchenko NM; Nesina IP; Brieieva OV; Iurchenko NP
    Exp Oncol; 2020 Dec; 42(4):300-305. PubMed ID: 33355863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
    Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
    Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.
    Ismail MF; Aly MS; Khaled HM; Mohamed HM
    Ger Med Sci; 2009 May; 7():Doc03. PubMed ID: 19675743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2/neu amplification and overexpression in endometrial carcinoma.
    Rolitsky CD; Theil KS; McGaughy VR; Copeland LJ; Niemann TH
    Int J Gynecol Pathol; 1999 Apr; 18(2):138-43. PubMed ID: 10202671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
    Saffari B; Jones LA; el-Naggar A; Felix JC; George J; Press MF
    Cancer Res; 1995 Dec; 55(23):5693-8. PubMed ID: 7585656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number signatures and CCNE1 amplification reveal the involvement of replication stress in high-grade endometrial tumors oncogenesis.
    Marlin R; Loger JS; Joachim C; Ebring C; Robert-Siegwald G; Pennont S; Rose M; Raguette K; Suez-Panama V; Ulric-Gervaise S; Lusbec S; Bera O; Vallard A; Aline-Fardin A; Colomba E; Jean-Laurent M
    Cell Oncol (Dordr); 2024 Aug; 47(4):1441-1457. PubMed ID: 38564163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
    Engelsen IB; Stefansson IM; Beroukhim R; Sellers WR; Meyerson M; Akslen LA; Salvesen HB
    Int J Oncol; 2008 Feb; 32(2):307-16. PubMed ID: 18202752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome aberrations [dup(1q)] in endometrial cancer: Gene analysis of 54 surgical specimens in Turkey.
    Sever E; Döğer E; Kumbasar S; Şık BA; Temur M; Yılmaz HT; Yılmaz Ö; Özbay PO; Yücesoy İ
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):357-62. PubMed ID: 27343315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome.
    Peiró G; Mayr D; Hillemanns P; Löhrs U; Diebold J
    Mod Pathol; 2004 Mar; 17(3):227-87. PubMed ID: 14752523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
    Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
    Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF; Liu MQ; Zhao Q
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma.
    Kuhn E; Bahadirli-Talbott A; Shih IeM
    Mod Pathol; 2014 Jul; 27(7):1014-9. PubMed ID: 24309323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
    Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
    Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
    Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.